News & Events about Ani Pharmaceuticals Inc.
Ticker Report
8 months ago
Equities research analysts forecast that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) will post earnings of $0.04 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for ANI Pharmaceuticals earnings, with the highest...
Business Wire
8 months ago
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual) Date: Tuesday, May 24...
Ticker Report
10 months ago
Thrivent Financial for Lutherans decreased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) by 3.5% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 7,834 shares of the specialty pharmaceutical companys stock after ...